These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8679248)
1. MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo. Lord BI Growth Factors; 1995; 12(2):145-9. PubMed ID: 8679248 [TBL] [Abstract][Full Text] [Related]
2. Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. Lord BI; Dexter TM; Clements JM; Hunter MA; Gearing AJ Blood; 1992 May; 79(10):2605-9. PubMed ID: 1586712 [TBL] [Abstract][Full Text] [Related]
3. BB-10010/MIP-1 alpha in vivo maintains haemopoietic recovery following repeated cycles of sublethal irradiation. Lord BI; Marshall E; Woolford LB; Hunter MG Br J Cancer; 1996 Oct; 74(7):1017-22. PubMed ID: 8855968 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of an inhibitor of haemopoietic stem cell proliferation. Graham GJ; Wright EG; Hewick R; Wolpe SD; Wilkie NM; Donaldson D; Lorimore S; Pragnell IB Nature; 1990 Mar; 344(6265):442-4. PubMed ID: 2320111 [TBL] [Abstract][Full Text] [Related]
5. Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide. Marshall E; Woolford LB; Lord BI Br J Cancer; 1997; 75(12):1715-20. PubMed ID: 9192972 [TBL] [Abstract][Full Text] [Related]
6. [Protection of hematopoietic stem cells by MIP-1alpha and PF4 against the cytotoxicity of chemotherapeutic agents]. Huang K; Huang S; Pan J; Wu Y Zhonghua Xue Ye Xue Za Zhi; 2000 Jul; 21(7):355-8. PubMed ID: 11877004 [TBL] [Abstract][Full Text] [Related]
7. Proliferation of spleen colony forming units (CFU-S8, CFU-S13) and cells with marrow repopulating ability. Lord BI; Woolford LB Stem Cells; 1993 May; 11(3):212-7. PubMed ID: 8318908 [TBL] [Abstract][Full Text] [Related]
8. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha. Cooper S; Mantel C; Broxmeyer HE Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739 [TBL] [Abstract][Full Text] [Related]
9. Biological and structural properties of MIP-1 alpha expressed in yeast. Clements JM; Craig S; Gearing AJ; Hunter MG; Heyworth CM; Dexter TM; Lord BI Cytokine; 1992 Jan; 4(1):76-82. PubMed ID: 1617159 [TBL] [Abstract][Full Text] [Related]
10. Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo. Quesniaux VF; Graham GJ; Pragnell I; Donaldson D; Wolpe SD; Iscove NN; Fagg B Blood; 1993 Mar; 81(6):1497-504. PubMed ID: 8453096 [TBL] [Abstract][Full Text] [Related]
11. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth. Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta: is it a downregulator of stem cell inhibition by macrophage inflammatory protein 1 alpha? Maltman J; Pragnell IB; Graham GJ J Exp Med; 1993 Sep; 178(3):925-32. PubMed ID: 8394405 [TBL] [Abstract][Full Text] [Related]
13. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells. Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722 [TBL] [Abstract][Full Text] [Related]
14. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice. Drize N; Chertkov J; Samoilina N; Zander A Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232 [TBL] [Abstract][Full Text] [Related]
15. Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen. Sefc L; Psenák O; Sýkora V; Sulc K; Necas E J Hematother Stem Cell Res; 2003 Feb; 12(1):47-61. PubMed ID: 12662436 [TBL] [Abstract][Full Text] [Related]
16. Polymerization of murine macrophage inflammatory protein 1 alpha inactivates its myelosuppressive effects in vitro: the active form is a monomer. Mantel C; Kim YJ; Cooper S; Kwon B; Broxmeyer HE Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2232-6. PubMed ID: 8460127 [TBL] [Abstract][Full Text] [Related]
18. BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties. Hunter MG; Bawden L; Brotherton D; Craig S; Cribbes S; Czaplewski LG; Dexter TM; Drummond AH; Gearing AH; Heyworth CM; Lord BI; McCourt M; Varley PG; Wood LM; Edwards RM; Lewis PJ Blood; 1995 Dec; 86(12):4400-8. PubMed ID: 8541527 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242 [TBL] [Abstract][Full Text] [Related]
20. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood. Suehiro Y; Muta K; Umemura T; Abe Y; Nishimura J; Nawata H Exp Hematol; 1999 Nov; 27(11):1637-45. PubMed ID: 10560911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]